Announced details
JAST conducted an analysis of 東洋ライス株式会社’s Kinmemai rice. Associate Professor Adachi Takahiro (安達貴弘) was responsible for conceiving and proposing the evaluation approach and for supervising the work. Capital and personnel relationships are not disclosed.
The location, representative, capital and year of establishment of 東洋ライス株式会社 are not disclosed. Institute of Science Tokyo is a university. Associate Professor Adachi Takahiro (安達貴弘) specializes in immunology, food functionality and mibyo research, and has research achievements in evaluating the health effects of functional foods and in preventive medicine.
The impact on business performance is not disclosed. JAST says it will consider the potential for creating new value and developing a sustainable business model in the future.
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | REZULT, Kinmemai rice |
| Counterparty | 東洋ライス株式会社, Institute of Science Tokyo, Institute of Integrated Research, Department of Mibyo Control, Associate Professor Adachi Takahiro (安達貴弘) |
| Counterparty overview | The location, representative, capital and year of establishment of 東洋ライス株式会社 are not disclosed. Institute of Science Tokyo is a university. Associate Professor Adachi Takahiro (安達貴弘) specializes in immunology, food functionality and mibyo research, and has research achievements in evaluating the health effects of functional foods and in preventive medicine. |
| Relationship with the Company | JAST conducted an analysis of 東洋ライス株式会社’s Kinmemai rice. Associate Professor Adachi Takahiro (安達貴弘) was responsible for conceiving and proposing the evaluation approach and for supervising the work. Capital and personnel relationships are not disclosed. |
| Applicable area | Municipal food policies, Health initiatives, EBPM (evidence-based policymaking), Data-driven decision-making in corporate activities and municipal initiatives |
| Impact on Business Performance | The impact on business performance is not disclosed. JAST says it will consider the potential for creating new value and developing a sustainable business model in the future. |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Against the backdrop of the need to objectively verify the effectiveness of municipal health initiatives and use the findings to improve subsequent measures, as well as the lack of a sufficiently established framework for third-party evaluations using medical data, JAST organized and developed an evaluation approach drawing on its expertise in the use of medical big data.